Recruiting
Thrombocytopenia
RecruitingA study to evaluate the effectiveness and safety of efaglomograstim alfa in patients with low blood platelet counts caused by chemotherapy
Investigational
A study to evaluate the effectiveness and safety of efaglomograstim alfa in patients with low blood platelet counts caused by chemotherapy
Investigational
- Disease:Thrombocytopenia
- Substances:Rafutrombopag ethanolamine
Countries:
Bulgaria
Bulgaria- Participants:18–64 years · 65+ years
- Substances:Rafutrombopag ethanolamine



